Spravato is approved to treat the following conditions in adults: SPRAVATO NASAL SPRAY.
- treatment-resistant depression (depression that doesn’t go away after you’ve tried at least two other antidepressants)
- major depressive disorder with suicidal thoughts and behaviors. Spravato nasal spray cost. Spravato contains the active ingredient esketamine. It belongs to a group of drugs called N-methyl-D-aspartate (NMDA) receptor blockers. Spravato is a brand-name medication
WHAT IS SPRAVATO
Spravato is a nasal spray that is used together with medication taken by mouth to treat adults with depression that is resistant to to other treatments.
Spravato is also used to treat depressive symptoms in adults with major depressive disorder (MDD) with suicidal thoughts or actions. Buy spravato nasal spray.
WHERE TO BUY KETAMINE SPRAY
Spravato is a brand-name prescription nasal spray. Esketamine or (S)-ketamine is the active ingredient in Spravato. It’s the ingredient that makes the drug work. buy crystal meth online
Esketamine is an enantiomer of ketamine — which is an arylcyclohexylamine drug with an impressive range of psychoactive and antidepressant effects. Spravato nasal spray reviews.
Ketamine is a racemic mixture (a 50:50 mixture) composed of equal amounts of two mirror molecules, (S)-ketamine and (R)-ketamine. Johnson & Johnson’s Spravato is the enantiopure form containing only (S)-ketamine. Spravato nasal spray buy online.
Ketamine is a Schedule III substance used as a general anesthetic and a dissociative drug. Patients who receive intravenous ketamine at a clinic receive both (S)-ketamine and (R)-ketamine. Spravato nasal spray dosage.
Preclinical data suggests the other enantiomer (pure (R)-ketamine) could be more potent and longer-acting than esketamine and ketamine [2] — but more research is needed. Spravato cost.
WHAT IS SPRAVATO USED FOR?
Spravato is a prescription drug approved by the Food and Drug Administration (FDA) for two conditions:
1. TREATMENT-RESISTANCE DEPRESSION (TRD)
Patients with major depressive disorder who have not responded to two or more oral antidepressants may have TRD. Physicians typically determine if a patient is suffering from TRD based on their history of antidepressant use. Spravato nasal spray price.
2. MAJOR DEPRESSIVE DISORDER (MDD) WITH SUICIDAL IDEATION OR BEHAVIORS
MDD is also known as clinical depression. Spravato is also used in patients with MDD who have suicidal thoughts or behaviors. Spravato for depression.
For both TRD and MDD, Spravato is prescribed alongside another oral antidepressant. It can be taken short or long-term. Esketamine for depression.
In addition, the patient administers the drug through the nose under the guidance of a doctor at a certified healthcare facility. This drug is approved for use in adults but not in pediatric patients (children). Esketamine nasal spray.
ESKETAMINE SIDE EFFECTS
You may expect to feel some of the following side effects after a Spravato treatment:
- Nausea and vomiting
- Sleepiness. Spravato treatment near me.
- Dizziness
- Dissociation
- Cognitive impairment
- Vertigo (feeling like the room’s spinning when it’s not). Spravato at home.
There’s an increased risk of Spravato causing suicidal thoughts and behaviors in adults ages 18 to 24. For example, the risk is highest during the first months of treatment or whenever the dosage is changed. How to get esketamine nasal spray.
SPRAVATO CLINICAL TRIALS
Therefore, there are a few clinical studies that show promising results for Spravato treatment. Esketamine treatment near me. Buy spravato online.
TREATMENT-RESISTANT DEPRESSION (TRD) CLINICAL STUDY
1. A Four-week Spravato Study for TRD
Firstly, a clinical study that lasted four weeks showed that Spravato reduced symptoms of treatment-resistant depression in diagnosed patients. Esketamine cost.
Secondly, the study was conducted on two groups. Thirdly, one group was given Spravato alongside an oral antidepressant. The other group was given a placebo and an oral antidepressant. Esketamine therapy.
The depression symptoms were measured on a scale of zero to 60, and the Spravato group showed a 4-point improvement more than the placebo group. Therefore, the biggest improvement was noticed within the first 24 hours of taking this drug. Esketamine nasal spray buy online.
A 4-week Spravato treatment is known as the Induction Phase. During this phase, the patient is administered two or three devices of esketamine (28 mg each) twice a week for a total of four weeks. Buy esketamine nasal spray online uk.
2. A Year-long Spravato Study for TRD
Following the 4-week trial, people who noticed a significant improvement in depression symptoms enrolled in a year-long study [3]. Esketamine uk nhs.
Similarly to the 4-week study, the year-long trial investigated Spravato versus placebo in two groups. Lastly, the study found that Spravato reduces symptoms of depression. Esketamine Scotland.
Patients who took the drug had a 51% to 70% lower chance of relapsing to severe depression compared to the placebo group. Esketamine dose.
Lastly, this extended treatment phase is known as the Maintenance Phase, where the dosage is personalized for each patient based on the outcome of previous treatment. Esketamine nasal spray dosage.
Major Depressive Disorder (MDD) Clinical Study
Therefore, one 4-week clinical study compared the effects of Spravato nasal spray (plus standard of care) versus placebo (plus standard of care) in two groups of patients diagnosed with moderate-to-severe MDD who had active suicidal ideation and intent. Buy spravato.
The study found that the depressive severity score in patients who administered Spravato was lower (less severe depressive symptoms) than in the placebo group. How to get spravato.
The study also revealed that Spravato plus standard care didn’t relieve patients’ suicidal severity within 24 hours after the first dose compared to the placebo.
Reviews
There are no reviews yet.